251 related articles for article (PubMed ID: 36778211)
1. The Gut Microbiota Metabolite Urolithin B Prevents Colorectal Carcinogenesis by Remodeling Microbiota and PD-L1/HLA-B.
Wang L; Chen J; Chen Q; Song H; Wang Z; Xing W; Jin S; Song X; Yang H; Zhao W
Oxid Med Cell Longev; 2023; 2023():6480848. PubMed ID: 36778211
[TBL] [Abstract][Full Text] [Related]
2. Chang Wei Qing Decoction enhances the anti-tumor effect of PD-1 inhibitor therapy by regulating the immune microenvironment and gut microbiota in colorectal cancer.
Wang T; Wu L; Wang S; Shi X; Liu H; Deng W
Chin J Nat Med; 2023 May; 21(5):333-345. PubMed ID: 37245872
[TBL] [Abstract][Full Text] [Related]
3. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
[No Abstract] [Full Text] [Related]
4. YYFZBJS ameliorates colorectal cancer progression in Apc
Sui H; Zhang L; Gu K; Chai N; Ji Q; Zhou L; Wang Y; Ren J; Yang L; Zhang B; Hu J; Li Q
Cell Commun Signal; 2020 Jul; 18(1):113. PubMed ID: 32677955
[TBL] [Abstract][Full Text] [Related]
5. The ellagic acid-derived gut microbiota metabolite, urolithin A, potentiates the anticancer effects of 5-fluorouracil chemotherapy on human colon cancer cells.
González-Sarrías A; Tomé-Carneiro J; Bellesia A; Tomás-Barberán FA; Espín JC
Food Funct; 2015 May; 6(5):1460-9. PubMed ID: 25857357
[TBL] [Abstract][Full Text] [Related]
6. The anti-colorectal cancer effect and metabolites of Agrimonia pilosa Ledeb.
Wang L; Chen Q; Song H; Xing W; Shi J; Li Y; Lv Y; Wang Z; Chen J; Zhao W
J Ethnopharmacol; 2024 Jul; 329():118146. PubMed ID: 38604512
[TBL] [Abstract][Full Text] [Related]
7. In vitro conversion of ellagic acid to urolithin A by different gut microbiota of urolithin metabotype A.
He F; Bian Y; Zhao Y; Xia M; Liu S; Gui J; Hou X; Fang Y
Appl Microbiol Biotechnol; 2024 Feb; 108(1):215. PubMed ID: 38363367
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota in colorectal cancer development and therapy.
Wong CC; Yu J
Nat Rev Clin Oncol; 2023 Jul; 20(7):429-452. PubMed ID: 37169888
[TBL] [Abstract][Full Text] [Related]
9. Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy.
Huang J; Liu D; Wang Y; Liu L; Li J; Yuan J; Jiang Z; Jiang Z; Hsiao WW; Liu H; Khan I; Xie Y; Wu J; Xie Y; Zhang Y; Fu Y; Liao J; Wang W; Lai H; Shi A; Cai J; Luo L; Li R; Yao X; Fan X; Wu Q; Liu Z; Yan P; Lu J; Yang M; Wang L; Cao Y; Wei H; Leung EL
Gut; 2022 Apr; 71(4):734-745. PubMed ID: 34006584
[TBL] [Abstract][Full Text] [Related]
10. The influence of gut microbiota dysbiosis to the efficacy of 5-Fluorouracil treatment on colorectal cancer.
Yuan L; Zhang S; Li H; Yang F; Mushtaq N; Ullah S; Shi Y; An C; Xu J
Biomed Pharmacother; 2018 Dec; 108():184-193. PubMed ID: 30219675
[TBL] [Abstract][Full Text] [Related]
11. Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice.
Wong SH; Zhao L; Zhang X; Nakatsu G; Han J; Xu W; Xiao X; Kwong TNY; Tsoi H; Wu WKK; Zeng B; Chan FKL; Sung JJY; Wei H; Yu J
Gastroenterology; 2017 Dec; 153(6):1621-1633.e6. PubMed ID: 28823860
[TBL] [Abstract][Full Text] [Related]
12. Fecal Microbiota Transplantation Prevents Intestinal Injury, Upregulation of Toll-Like Receptors, and 5-Fluorouracil/Oxaliplatin-Induced Toxicity in Colorectal Cancer.
Chang CW; Lee HC; Li LH; Chiang Chiau JS; Wang TE; Chuang WH; Chen MJ; Wang HY; Shih SC; Liu CY; Tsai TH; Chen YJ
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936237
[TBL] [Abstract][Full Text] [Related]
13. Structural shift of gut microbiota during chemo-preventive effects of epigallocatechin gallate on colorectal carcinogenesis in mice.
Wang X; Ye T; Chen WJ; Lv Y; Hao Z; Chen J; Zhao JY; Wang HP; Cai YK
World J Gastroenterol; 2017 Dec; 23(46):8128-8139. PubMed ID: 29290650
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of SR-B1 reduced the tumor load of colitis-induced or APC
Chen Q; Wang L; Song H; Xing W; Shi J; Li Y; Wang Z; Chen J; Xie N; Zhao W
Cancer Med; 2023 Oct; 12(19):19744-19757. PubMed ID: 37766594
[TBL] [Abstract][Full Text] [Related]
15. 5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers.
Van Der Kraak L; Goel G; Ramanan K; Kaltenmeier C; Zhang L; Normolle DP; Freeman GJ; Tang D; Nason KS; Davison JM; Luketich JD; Dhupar R; Lotze MT
J Immunother Cancer; 2016; 4():65. PubMed ID: 27777774
[TBL] [Abstract][Full Text] [Related]
16. Impact of 5 fluorouracil chemotherapy on gut inflammation, functional parameters, and gut microbiota.
Sougiannis AT; VanderVeen BN; Enos RT; Velazquez KT; Bader JE; Carson M; Chatzistamou I; Walla M; Pena MM; Kubinak JL; Nagarkatti M; Carson JA; Murphy EA
Brain Behav Immun; 2019 Aug; 80():44-55. PubMed ID: 30807838
[TBL] [Abstract][Full Text] [Related]
17. The Role of the Microbiome in the Etiopathogenesis of Colon Cancer.
El Tekle G; Andreeva N; Garrett WS
Annu Rev Physiol; 2024 Feb; 86():453-478. PubMed ID: 38345904
[TBL] [Abstract][Full Text] [Related]
18. Augmented Antitumor Effect of Unripe
Lee EJ; Yang JH; Choi JG; Chung HS
Cells; 2022 Sep; 11(18):. PubMed ID: 36139451
[TBL] [Abstract][Full Text] [Related]
19. Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment.
Hanus M; Parada-Venegas D; Landskron G; Wielandt AM; Hurtado C; Alvarez K; Hermoso MA; López-Köstner F; De la Fuente M
Front Immunol; 2021; 12():612826. PubMed ID: 33841394
[TBL] [Abstract][Full Text] [Related]
20. A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis.
Chen H; Zhang F; Zhang J; Zhang X; Guo Y; Yao Q
Front Immunol; 2020; 11():588079. PubMed ID: 33072135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
